The pilot will focus on individual patient data from clinical studies in electronic structured formats that are “accessible for analysis and visualisation,” said the EU regulator.
That could include original observations and measurements of clinical study participants, such as lab results, imaging data, and patient medical charts. It has been quick to give reassurance that any analysis of patient data will comply with the EU’s data protection requirements.
